Portal Vein Thrombosis Clinical Trial
Official title:
Vienna Vascular Liver Disease Study: Characterization of Patients With Vascular Liver Disease - a Registry With Biobank
The aim of this Register Trial is to systematically study the epidemiology, risk factors, liver function as well prognosis of patients with vascular liver diseases. Furthermore, important clinical parameters will be assessed in order to evaluate patients' coagulation status and in order to develop new biomarkers derived from blood, urine, stool or ascites of patients as well as histological samples from the upper / lower GI-tract or the liver in order to better understand the natural history of vascular liver diseases.
We will include patients with vascular liver diseases, including - portal vein thrombosis (PVT) - Budd-Chiari Syndrome (BCS) - Heredetary Hemorrhagic Teleangiectasia (HHT, or Osler-Rendu Disease) - Noncirrhotic-portal hypertension (NCPH) and Porto-sinusoidal vascular disorder - Cirrhosis cardiaque if the fulfill inclusion/exclusion criteria and provide written informed consent. Participation in the biobank is optional for the patients. In particular, we will study the natural course of the patients in regard to hepatic decompensation (ascites, variceal bleeding, hepatic encephalopathy), need for intensified treatment (TIPS, ICU, liver transplantation) and survival. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03631147 -
The Effect of Rifaximin on Portal Vein Thrombosis
|
N/A | |
| Completed |
NCT02250391 -
Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis
|
Phase 3 | |
| Recruiting |
NCT05625893 -
Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion
|
Phase 2 | |
| Completed |
NCT05012501 -
Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis Patients
|
||
| Terminated |
NCT00769873 -
Anticoagulation Post Laparoscopic Splenectomy
|
Phase 2 | |
| Recruiting |
NCT05123326 -
Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome
|
||
| Completed |
NCT01095185 -
Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding
|
Phase 3 | |
| Completed |
NCT02585713 -
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
|
Phase 3 | |
| Not yet recruiting |
NCT06117488 -
Risk Factors and Management Outcome of Chronic Portal Vein Thrombosis in Children
|
||
| Completed |
NCT01326949 -
Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
|
N/A | |
| Not yet recruiting |
NCT05339581 -
IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation
|
N/A | |
| Recruiting |
NCT03902678 -
Role of EUS Guided FNA of Portal Vein Thrombus in the Diagnosis and Staging of Hepatocellular Carcinoma
|
N/A | |
| Not yet recruiting |
NCT06319131 -
Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT
|
N/A | |
| Recruiting |
NCT03193502 -
Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis
|
Phase 3 | |
| Completed |
NCT03201367 -
Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV
|
N/A | |
| Completed |
NCT03477149 -
EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications
|
N/A | |
| Recruiting |
NCT02398357 -
The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis
|
Phase 4 | |
| Completed |
NCT01556282 -
TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis
|
N/A | |
| Withdrawn |
NCT01631877 -
Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver
|
N/A | |
| Recruiting |
NCT04433481 -
Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis
|
N/A |